Royal Philips acquires PathXL, hopes to boost digital pathology industry

Dutch healthcare technology company Royal Philips bought the Northern Irish pathology image analysis firm PathXL, Royal Philips announced June 21.

PathXL’s programs will join Philips’ Digital Pathology Solutions in an effort to offer a better product that will help bring more medical institutions into the digital pathology fray.

Philips Digital Pathology Solutions General Manager Russ Granzow explained in a statement their new, combined program will be a better option for “computational pathology, education, workflow solutions and image analytics” than either one was on its own.

“With this acquisition, we are accelerating our drive to support global medical institutions in their transition to digitized pathology workflows,” he said. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.